Skip to main content

Featured Content

A decision made by HHS in the waning days of the Trump presidency to publish new guidelines that include an exemption from certain requirements under the Controlled Substances Act for physicians who are licensed under state law and possess DEA registration to prescribe buprenorphine appears to be poised for reversal under the Biden administration.
A survey of physicians in 24 nations that was released on Tuesday morning showed that 86% believe mental health issues and depression, along with an increase in opioid abuse, will be the top non-COVID-19 public health issue after the pandemic.
A study conducted by physician researchers the University of Texas Health Science Center at Houston has found that a new pain management regimen for trauma patients that uses mostly over-the-counter medications reduces opioid exposure while providing a comparable level of pain control as other forms of treatment.
As part of its Project DAWN initiative, MetroHealth in Cleveland has outfitted an RV it can use to distribute naloxone, serve as a syringe exchange and provide other resources to at-risk individuals in Northeast Ohio.
Toronto-based Awakn Life Sciences and contract research organization PRA Health Sciences have announced plans to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder.

Meetings & Publications

Back to Top